vs

Side-by-side financial comparison of NexPoint Residential Trust, Inc. (NXRT) and Neuronetics, Inc. (STIM). Click either name above to swap in a different company.

NexPoint Residential Trust, Inc. is the larger business by last-quarter revenue ($62.1M vs $41.8M, roughly 1.5× Neuronetics, Inc.). On growth, Neuronetics, Inc. posted the faster year-over-year revenue change (85.7% vs -2.7%). Over the past eight quarters, Neuronetics, Inc.'s revenue compounded faster (54.9% CAGR vs -4.1%).

NexPoint Residential Trust, Inc. is a publicly traded real estate investment trust focused on acquiring, renovating, and operating multifamily residential properties primarily across high-growth Sun Belt markets in the United States. Its portfolio consists mainly of affordable and mid-tier apartment communities, targeting steady rental income growth and long-term asset value appreciation for investors.

Neuronetics is a Malvern, PA based, publicly traded company incorporated in Delaware in April 2003, that develops non-invasive treatments for psychiatric disorders that have shown resistance or lack of improvement using traditional medicine. The treatments are based upon neuromodulation technology. 

NXRT vs STIM — Head-to-Head

Bigger by revenue
NXRT
NXRT
1.5× larger
NXRT
$62.1M
$41.8M
STIM
Growing faster (revenue YoY)
STIM
STIM
+88.4% gap
STIM
85.7%
-2.7%
NXRT
Faster 2-yr revenue CAGR
STIM
STIM
Annualised
STIM
54.9%
-4.1%
NXRT

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
NXRT
NXRT
STIM
STIM
Revenue
$62.1M
$41.8M
Net Profit
$-7.2M
Gross Margin
52.0%
Operating Margin
8.4%
-12.1%
Net Margin
-17.2%
Revenue YoY
-2.7%
85.7%
Net Profit YoY
43.2%
EPS (diluted)
$-0.10

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
NXRT
NXRT
STIM
STIM
Q4 25
$62.1M
$41.8M
Q3 25
$62.8M
$37.3M
Q2 25
$63.1M
$38.1M
Q1 25
$63.2M
$32.0M
Q4 24
$63.8M
$22.5M
Q3 24
$64.1M
$18.5M
Q2 24
$64.2M
$16.4M
Q1 24
$67.6M
$17.4M
Net Profit
NXRT
NXRT
STIM
STIM
Q4 25
$-7.2M
Q3 25
$-7.8M
$-9.0M
Q2 25
$-7.0M
$-10.1M
Q1 25
$-6.9M
$-12.7M
Q4 24
$-12.7M
Q3 24
$-8.9M
$-13.3M
Q2 24
$10.6M
$-9.8M
Q1 24
$26.3M
$-7.9M
Gross Margin
NXRT
NXRT
STIM
STIM
Q4 25
52.0%
Q3 25
45.9%
Q2 25
46.6%
Q1 25
49.2%
Q4 24
66.2%
Q3 24
75.6%
Q2 24
74.0%
Q1 24
75.1%
Operating Margin
NXRT
NXRT
STIM
STIM
Q4 25
8.4%
-12.1%
Q3 25
11.8%
-19.6%
Q2 25
12.5%
-21.1%
Q1 25
11.7%
-34.4%
Q4 24
18.0%
-51.0%
Q3 24
8.7%
-41.7%
Q2 24
39.7%
-51.7%
Q1 24
60.7%
-39.4%
Net Margin
NXRT
NXRT
STIM
STIM
Q4 25
-17.2%
Q3 25
-12.4%
-24.3%
Q2 25
-11.1%
-26.6%
Q1 25
-10.9%
-39.6%
Q4 24
-56.4%
Q3 24
-13.8%
-72.0%
Q2 24
16.5%
-59.8%
Q1 24
38.9%
-45.2%
EPS (diluted)
NXRT
NXRT
STIM
STIM
Q4 25
$-0.10
Q3 25
$-0.31
$-0.13
Q2 25
$-0.28
$-0.15
Q1 25
$-0.27
$-0.21
Q4 24
$-0.34
Q3 24
$-0.35
$-0.44
Q2 24
$0.40
$-0.33
Q1 24
$1.00
$-0.27

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
NXRT
NXRT
STIM
STIM
Cash + ST InvestmentsLiquidity on hand
$13.7M
$28.1M
Total DebtLower is stronger
$1.6B
$65.8M
Stockholders' EquityBook value
$295.5M
$22.4M
Total Assets
$1.9B
$141.6M
Debt / EquityLower = less leverage
5.39×
2.94×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
NXRT
NXRT
STIM
STIM
Q4 25
$13.7M
$28.1M
Q3 25
$10.8M
$28.0M
Q2 25
$13.6M
$11.0M
Q1 25
$23.7M
$20.2M
Q4 24
$23.1M
$18.5M
Q3 24
$17.4M
$20.9M
Q2 24
$21.3M
$42.6M
Q1 24
$37.2M
$47.7M
Total Debt
NXRT
NXRT
STIM
STIM
Q4 25
$1.6B
$65.8M
Q3 25
$65.7M
Q2 25
$55.5M
Q1 25
$55.3M
Q4 24
$55.2M
Q3 24
$46.0M
Q2 24
$59.8M
Q1 24
$1.5B
$59.4M
Stockholders' Equity
NXRT
NXRT
STIM
STIM
Q4 25
$295.5M
$22.4M
Q3 25
$322.9M
$27.4M
Q2 25
$347.9M
$27.1M
Q1 25
$379.9M
$35.5M
Q4 24
$410.4M
$27.7M
Q3 24
$447.1M
$9.4M
Q2 24
$491.1M
$19.4M
Q1 24
$512.8M
$27.7M
Total Assets
NXRT
NXRT
STIM
STIM
Q4 25
$1.9B
$141.6M
Q3 25
$1.8B
$145.5M
Q2 25
$1.9B
$134.7M
Q1 25
$1.9B
$142.0M
Q4 24
$1.9B
$140.9M
Q3 24
$2.0B
Q2 24
$2.0B
$96.8M
Q1 24
$2.0B
$103.8M
Debt / Equity
NXRT
NXRT
STIM
STIM
Q4 25
5.39×
2.94×
Q3 25
2.40×
Q2 25
2.05×
Q1 25
1.56×
Q4 24
1.99×
Q3 24
4.90×
Q2 24
3.08×
Q1 24
2.92×
2.15×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
NXRT
NXRT
STIM
STIM
Operating Cash FlowLast quarter
$83.6M
$908.0K
Free Cash FlowOCF − Capex
$692.0K
FCF MarginFCF / Revenue
1.7%
Capex IntensityCapex / Revenue
0.5%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$-21.2M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
NXRT
NXRT
STIM
STIM
Q4 25
$83.6M
$908.0K
Q3 25
$29.3M
$-785.0K
Q2 25
$19.9M
$-3.5M
Q1 25
$28.3M
$-17.0M
Q4 24
$73.6M
$-8.6M
Q3 24
$27.8M
$-5.4M
Q2 24
$19.7M
$-5.0M
Q1 24
$19.7M
$-12.0M
Free Cash Flow
NXRT
NXRT
STIM
STIM
Q4 25
$692.0K
Q3 25
$-899.0K
Q2 25
$-3.8M
Q1 25
$-17.2M
Q4 24
$-8.7M
Q3 24
$-5.8M
Q2 24
$-5.6M
Q1 24
$-12.4M
FCF Margin
NXRT
NXRT
STIM
STIM
Q4 25
1.7%
Q3 25
-2.4%
Q2 25
-9.9%
Q1 25
-53.8%
Q4 24
-38.6%
Q3 24
-31.3%
Q2 24
-34.0%
Q1 24
-71.1%
Capex Intensity
NXRT
NXRT
STIM
STIM
Q4 25
0.5%
Q3 25
0.3%
Q2 25
0.7%
Q1 25
0.7%
Q4 24
0.4%
Q3 24
2.1%
Q2 24
3.7%
Q1 24
2.2%
Cash Conversion
NXRT
NXRT
STIM
STIM
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
Q3 24
Q2 24
1.86×
Q1 24
0.75×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons